Virax
  • Home
  • Trial Info
  • Corporate
  • Announcements
  • Recent Press Articles
  • Investor Information
  • Virax's Technology
  • Development Products
Virax is developing immunotherapies that boost the immune system to treat a broad range of diseases.
  • Share price
  • Contact us
  • Subscribe
  • Appendix 4E - 31 August 2010
    Tuesday 31 August 2010
  • VIR201 HIV Vaccine Phase IIa Trial Results - 16 August 2010
    Monday 16 August 2010
  • Positive effect of VIR201 HIV Vaccine published in AIDS Journal - 12 August 2010
    Thursday 12 August 2010
  • More announcements
Information Pack

To receive an updated
information pack
please contact us.

*Printer-friendly version

© Copyright Virax 2008. All rights reserved. Site index Legal Contact Us

DDSN Interactive Website Design Melbourne Australia, Web Hosting, Web Development by DDSN InteractiveVirax is built and powered by CM3